Tuesday, March 3, 2009

Genentech

It's true that the precious-unique-culture stuff can be overemphasized. Roche has indeed been insisting that they want to preserve Genentech's entrepreneurial spirit (although, to be honest, they'd say that no matter what they were really thinking - what are they going to do, say that they really just want all the Avastin revenue and whatever else is high up in the pipeline?) And, as the article correctly points out, there have been any number of good-sized biotech outfits taken over by Big Pharma over the years.

But what worries me a bit is what's happened to some of those biotechs. It really is rare, from what I can see, for a company's culture to stay the same after something like this happens. It's a bit like those singers who make it big from obscurity; you read these articles saying that they're just the same small-town person that they always were. Right - that would be the least likely outcome of them all.
The thing is, the atmosphere of the acquiring company is going to seep in, no matter what. The new projects are going to be approved using the processes of the larger company, aren't they? They'll be expected to fit into a new, larger picture, and to find their place. And the compounds that advance will advance against the larger company's criteria, not the ones in place under the old regime.

Those are just the direct effects on research. What might be a larger difference is a psychological one. As a stand-alone company, even one the size of Genentech, you live by your own wits, but that changes. As part of a larger company, you know that there are other projects out there, other divisions, and that some of these will be expected to pick up the slack now and then. It's a big company, after all. It'll keep going, even if you don't deliver this year. Right? That's actually one of the trickier parts about running a company with a lot of sites and research areas - the inevitable frictions when one group or another feels (sometimes correctly) that they're being leaned on more than those lazy bums over in XYZ, who haven't delivered a clinical candidate since (fill in the year).



[Sigma Forex Practice Accounts]

Learn And Develop your trading skills with Sigma platform!

A Free practice account is a great way to experience the Forex market without risking any money.

For Novice Traders
For those who did not trade in the forex market before can get accustomed to following a market, and open themselves to a whole new way to invest, and it also gives them the chance to understand how the trading platform works.

For Regular Traders
For those who are familliar with trading in forex market, a practice account can help them to get use to the particular characteristics of the Forex market or our trading platform.

For Experienced and Professional Traders
A practice account can even help experienced and professional traders as they can test and practice their trading strategies without risking capital.
Generally the Demo Account has the same capabilities of the real account, the only difference between them is that the real account is with real money and the practice account is with virtual money.

Open Now A Free $ 500'000 Account With Sigma Forex and discover a whole new way to invest.
Sigma Account allow you to open Micro, Mini and Standard lot through only one account and trade in Forex Market
In order to register for a practice account, please Download Sigma Forex Platform and open new account as illustrated below and you will have unlimited access to our Platform for the next 30-days.

If you have any problem regarding Sigma Practice Account you can see User Guides or click on the Live Chat button on the right menu and our customer support staff will help you through the process.

No comments: